ESF-30470-37755 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-09
Registered in v-safe
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
2021-04-09
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-16
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-23
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-05-01
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-05-07
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-05-14
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-05-23
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-10-08
Survey response — 6 months, dose 1
MedDRA: Eye inflammation, Respiratory tract infection viral — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Viral respiratory infection and eye inflammation

MedDRA releases: 2024-11 · check-in free text available
2021-10-08
Report sent to call center — 6 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-10-11
Call 1 — Left Voicemail
2022-04-11
Survey response — 12 months, dose 1
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid infection January 2022

MedDRA releases: 2024-11 · check-in free text available
2022-04-11
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-04-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-09	Janssen/Johnson & Johnson

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — 6 months, dose 1

2021-10-08

Symptoms: Viral respiratory infection and eye inflammation

Release 11 — 12 months, dose 1

2022-04-11

Symptoms: Covid infection January 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Eye inflammation	·	·	✓
SD	Respiratory tract infection viral	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release